ADMA Adma Biologics Inc

ADMA Biologics Inc is a biopharmaceutical company. The Company develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases.

$3.32  -0.01 (-0.15%)
As of 03/27/2023 14:02:18 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/17/2013
Outstanding shares:  196,777,308
Average volume:  2,948,349
Market cap:   $611,977,428
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      B9NSBM2

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%